According to PwC's Issues and Decisions: A Report on the Australian Pharmaceutical Industry, better health outcomes for the nation can be achieved by greater collaboration between the pharmaceutical industry and government regulators to improve access to and pricing of new medicines.
Based on a survey of industry participants from pharmaceutical companies, wholesalers and industry peak bodies, the report brings together a 'whole of industry' picture of views, concerns, emerging issues and trends.
The survey was carried out between December 2012 and March 2013 and respondents represented (in 2012); 17 of the top 20 pharmaceutical companies, in terms of PBS value, and $7.1billion of the circa$9 billion pharmaceuticals market in Australia.
© 2017 - Tue Dec 12 20:52:31 EST 2017 PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details. Liability limited by a scheme approved under Professional Standards Legislation.